1,30 $
1,56 %vorgestern
Nasdaq, 1. März, 22:00 Uhr
ISIN
US59503A1051
Symbol
MBOT
Berichte
Sektor
Industrie

Microbot Medical Inc Aktie News

Neutral
GlobeNewsWire
27 Tage alt
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application
Neutral
GlobeNewsWire
etwa ein Monat alt
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot's insurance carrier and will not impact company's cash position All of the cash payable to the plaintiffs in the settlement will be covered by Microbot's insurance carrier and will not impact company's cash position
Neutral
GlobeNewsWire
etwa 2 Monate alt
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study
Neutral
GlobeNewsWire
2 Monate alt
BRAINTREE, Mass., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 1,685,682 shares of common stock, having exercise prices ranging ...
Neutral
MCAP MediaWire
2 Monate alt
New York, December 28, 2023 – Microbot Medical Inc. (Nasdaq: MBOT) has completed its GLP pivotal pre-clinical study for the LIBERTY® Endovascular Robotic Surgical System. The study, adhering to FDA guidelines and using a porcine model, successfully met all its objectives, including conducting 96 robotic navigations by three interventional radiologists.
Neutral
GlobeNewsWire
2 Monate alt
The results of the study will support the Company's IDE submission to the FDA to commence its human clinical study The results of the study will support the Company's IDE submission to the FDA to commence its human clinical study
Neutral
GlobeNewsWire
3 Monate alt
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments
Positiv
InvestorPlace
3 Monate alt
Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy. Sure, you can gamble on just about anything these days and a non-zero probability exists for their upside.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen